Related Experiment Videos

[Relationship and interactions between elevated fasting glucose and hypertension for cardiocerebral vascular disease]

Yi-qiang Zhan1, Jin-ming Yu, Da-yi Hu

  • 1School of Public Health, Fudan University, Shanghai, China.

Insights

Elevated fasting glucose and hypertension showed additive interaction on cardiovascular disease risk in Beijing adults. This interaction, particularly with diabetes, highlights a significant combined impact on heart health.

Area of Science:

  • Cardiovascular epidemiology
  • Metabolic disease research
  • Public health

Context:

  • Cardiocerebral vascular disease poses a significant health burden.
  • Understanding the interplay of metabolic and hypertensive disorders is crucial for prevention.
  • Previous research has explored individual risk factors, but interaction effects require further investigation.

Purpose:

  • To investigate the relationship and interaction between elevated fasting glucose and hypertension on cardiocerebral vascular disease.
  • To analyze both multiplicative and additive interactions between these two risk factors.
  • To quantify the interaction effect using measures like RERI, AP, and S.

Summary:

  • A cross-sectional study of 10,054 individuals examined the combined effects of fasting glucose and hypertension on cardiocerebral vascular disease.
  • No statistically significant multiplicative interaction was found between elevated fasting glucose and hypertension.
  • Significant additive interaction was observed between diabetes and hypertension for cardiovascular disease, but not for stroke.

Impact:

  • The findings indicate that while hypertension and diabetes are independent risk factors for cardiovascular events, their combination has a synergistic effect on cardiovascular disease.
  • This highlights the importance of managing both conditions concurrently to mitigate cardiocerebral vascular disease risk.
  • Public health strategies should consider the additive interaction of diabetes and hypertension for effective cardiovascular disease prevention programs.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...